Contract Pharma

Breaking News | Financial Reports

Pfizer's 2Q Revenues Up 92%

COVID-19 vaccine BNT162b2 contributes $7.8 billion in sales and alliance revenues.

07.29.21

Breaking News | Industry News

U.S. Govt. Buys Additional 200M Doses of Pfizer-BioNTech COVID Vax

Additional doses will help the U.S. government ensure broad vaccine access into next year.

07.23.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Pfizer, BioNTech Partner with Biovac for COVID-19 Vax in Africa

Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network.

07.21.21

07 Pfizer

...

07.16.21

Biologics, Proteins, Vaccines | Industry News

Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation

Doses to be donated to approximately 100 low- and lower middle-income countries.

06.10.21

Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine

Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.

Tim Wright, Editor, Contract Pharma 06.07.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Pfizer, BioNTech to Supply EU with Additional COMIRNATY Doses

To supply 900 million doses to European Commission, with option to request an additional 900 million doses, beginning December 2021 – 2023.

Kristin Brooks 05.20.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Pfizer, BioNTech to Supply Additional COVID-19 Vax Doses to Turkey

To supply 60 million additional doses of the companies’ COVID-19 vaccine, with an option for an additional 30 million doses to be delivered in 2021.

Kristin Brooks 05.20.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

FDA Expands EUA for Pfizer, BioNTech’s Covid-19 Vax

Expands the authorization to include individuals 12-15 years of age.

Charles Sternberg, Assistant Editor 05.11.21

Financial Reports

Pfizer 1Q Revenues up 45% Driven by COVID Vax

Vaccine sales were $4.9 billion in the quarter, with BNT162b2 contributing $3.5 billion in global revenues.

Kristin Brooks 05.05.21

Breaking News | Clinical Trials | Drug Development | Industry News

Pfizer Acquires Amplyx Pharmaceuticals

Deal expands anti-infectives pipeline with addition of novel antifungal Phase 2 candidate, Fosmanogepix (APX001).

Tim Wright, Editor, Contract Pharma 04.29.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.

Tim Wright, Editor, Contract Pharma 04.19.21

WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China

Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.

Tim Wright, Editor, Contract Pharma 03.17.21

Breaking News | Collaborations & Alliances | Drug Development | Industry News | Solid Dosage/Creams/Ointments

Pfizer Partners with Medicines Manufacturing Innovation Center

To transform the formulation of oral solid dosage medicines.

Tim Wright, Editor, Contract Pharma 02.25.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology

Pfizer Selects Seven Bridges to Support RNA Sequencing Data

Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.

Kristin Brooks 02.24.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech To Supply 200M More Vax Doses to EU

New agreement brings total supply to the European Union to 500 million doses, with delivery expected by the end of 2021.

Charles Sternberg, Assistant Editor 02.17.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech to Supply the U.S. with 100mn Additional Doses of COVID-19 Vaccine

U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people.

Tim Wright, Editor, Contract Pharma 02.12.21

Financial Reports

Pfizer's 4Q Revenues up 12%

COVID-19 vaccine BNT162b2, which was granted an EUA in the U.S. in December 2020, contributed $154 million in sales in the quarter.

Kristin Brooks 02.09.21

March 2021: Pfizer Havant Sale #2

Upcoming auction March 10-11, 2021 featuring state-of-the-art process and packaging equipment from Pfizer’s facility in Havant, United Kingdom.

Breaking News | Collaborations & Alliances | Drug Development

Imcyse, Pfizer Enter Autoimmune Research Alliance

Will develop Imotope candidates to potentially treat Rheumatoid Arthritis.

Charles Sternberg, Assistant Editor 02.03.21

Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine

Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.

Tim Wright, Editor, Contract Pharma 01.29.21

Breaking News | Industry News

Pfizer, BioNTech Enter Vax Pact with COVAX

Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.

Kristin Brooks 01.22.21

Breaking News | Promotions & Moves

Pfizer Appoints President of AfME Region

Patrick van der Loo’s experience spans more than 20 years at Pfizer in leadership roles across multiple geographies.

Contract Pharma Staff 01.12.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech Covid-19 Vax Authorized in the U.S.

First doses to be delivered across the nation today in healthcare facilities.

Contract Pharma Staff 12.14.20

Breaking News | Industry News | Trials & Filings

Health Canada Authorizes Pfizer, BioNTech COVID-19 Vax

Pfizer Canada and BioNTech will supply the Government of Canada a minimum of 20 million doses and up to 76 million doses of the vaccine through 2021.

Contract Pharma Staff 12.10.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Trials & Filings

Pfizer, BioNTech Win First Authorization for COVID-19 Vax

MHRA authorizes supply of BNT162b2 vaccine for emergency supply; companies are ready to deliver the first doses to the U.K. immediately.

Contract Pharma Staff 12.02.20

Pfizer, BioNTech Submit CMA for Covid-19 Vax to EMA

Approval could potentially enable the use of BNT162b2 in Europe before the end of 2020.

Contract Pharma Staff 12.01.20

Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine

Expect to produce globally up to 50 million doses in 2020, up to 1.3 billion doses by the end of 2021; ready to distribute within hours after authorization.

Contract Pharma Staff 11.20.20

Biologics, Proteins, Vaccines | cGMP Manufacture

Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France

Will begin manufacturing BNT 162b2 in April 2021 and will produce tens of millions of doses.

Contract Pharma Staff 11.19.20

Trials & Filings

Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study

Meets all primary efficacy endpoints, demonstrates BNT162b2 to be 95% effective against COVID-19.

Contract Pharma Staff 11.18.20

Pfizer’s COVID-19 Vax Breakthrough

mRNA-based vaccine candidate found to have an efficacy rate above 90% in preventing COVID-19.

Tim Wright, Editor 11.17.20

Breaking News | Industry News

Pfizer, BioNTech to Supply 200M Doses of BNT162b2 to EU

Deliveries are anticipated to start by the end of 2020, subject to clinical success and regulatory authorization.

Contract Pharma Staff 11.11.20

Biologics, Proteins, Vaccines | Breaking News | Industry News

Pfizer, BioNTech COVID-19 Vax Candidate Successful in Phase III Interim Analysis

mRNA-based vaccine candidate BNT162b2 found to be more than 90% effective in preventing COVID-19.

Contract Pharma Staff 11.09.20

Financial Reports

Financial Report: Pfizer

Revenues down 4% in the quarter to $12.1 billion.

Contract Pharma Staff 11.04.20

Breaking News | Collaborations & Alliances | Drug Development | Industry News

CStone, Pfizer Enter Antibody Alliance

To support CStone’s development of sugemalimab, a potential best-in-class PD-L1 antibody being developed for high-incidence cancer indications in China.

Contract Pharma Staff 09.30.20

November 2020: Auction of Packaging Equipment of Vaccines and Injectable Products from Pfizer Havant

United Kingdom

Breaking News | Industry News | Promotions & Moves

Pfizer CentreOne Appoints General Manager

Andrew Moore joins the company from CogxVision.

Contract Pharma Staff 09.14.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU

Could supply the EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2.

Contract Pharma Staff 09.10.20

Biologics, Proteins, Vaccines | Breaking News | Industry News

Florence, Pfizer Partner to Support COVID-19 Vax

Global Phase 2/3 study to leverage site and sponsor connectivity platform across 27 countries.

Contract Pharma Staff 09.09.20

Breaking News | Clinical Trials | Collaborations & Alliances | Toxicology

NKMax America Partners with Merck KGaA and Pfizer

Will evaluate the safety and tolerability of SNK01 in combination with avelumab (BAVENCIO).

Contract Pharma Staff 09.09.20

Breaking News | Clinical Trials | Drug Development | Industry News

Parexel, Pfizer Extend Long-Term Partnership

Parexel will provide clinical development services via full-service, hybrid and functional service provider (FSP) models across all therapeutic areas.

Contract Pharma 08.27.20

Bio News | Breaking News | Collaborations & Alliances | Industry News

Pfizer, Gilead Partner to Manufacture Remdesivir for Treatment of COVID-19

Pfizer will provide contract manufacturing services at its McPherson, KS facility.

Contract Pharma Staff 08.13.20

Financial Reports

Financial Report: Pfizer

Biopharma revenues were $9.8 billion, up 6% operationally, primarily driven by Vyndaqel.

Contract Pharma Staff 08.12.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Pfizer, BioNTech Reach Deal with Japanese Government

Supply of 120 million vaccine doses to be provided in the first half of 2021, subject to regulatory approval.

Contract Pharma Staff 08.03.20

Breaking News | Clinical Trials | CRO News | Drug Development | Laboratory Testing

PPD, Pfizer Ink New Service Pact

PPD to provide drug development services to advance Pfizer’s portfolio under new three-year agreement.

Contract Pharma Staff 08.03.20

U.S. Inks $2B COVID-19 Vax Deal with Pfizer, BioNTech

U.S. government placed an initial order of 100 million doses and can acquire up to 500 million additional doses.

Contract Pharma Staff 07.23.20

01 Pfizer, Inc.

...

Tim Wright, Editor, Contract Pharma 07.15.20

Breaking News | Clinical Trials | CRO News | Drug Development

Syneos Health, Pfizer Ink New Service Agreement

Three-year agreement to provide global product development services to support Pfizer's portfolio.

Contract Pharma Staff 07.13.20

EMD Serono, Pfizer Win FDA Approval for sBLA for BAVENCIO

For the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma.

Contract Pharma Staff 07.01.20

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

BioInvent, Pfizer Extend Immunotherapy Research Term

Allows the companies to further identify and characterize new targets and antibodies leveraging BioInvent's F.I.R.S.T drug discovery platform.

Contract Pharma Staff 07.01.20

FOLLOW:

Search Results for 'pfizer'

Contract Service Directory Companies

Featured Companies

July/August 2021

follow us